Aarti Drugs share price
You have to be logged in to add this to Watchlist.Aarti Drugs is trading 1.05% upper at Rs 453.70 as compared to its last closing price. Aarti Drugs has been trading in the price range of 460.90 & 451.55. Aarti Drugs has given -8.17% in this year & -3.88% in the last 5 days.
Aarti Drugs has TTM P/E ratio 30.88 as compared to the sector P/E of 33.29.
The company posted a net profit of 35.01 Crores in its last quarter.
Listed peers of Aarti Drugs include Hikal (0.86%), Solara Active Pharma Sciences (-1.48%), Aarti Drugs (1.05%) etc.
Aarti Drugs has a 44.36% public holding.The Mutual Fund holding in Aarti Drugs was at 6.25% in 30 Sep 2024. The MF holding has increased from the last quarter. The FII holding in Aarti Drugs was at 2.50% in 30 Sep 2024. The FII holding has decreased from the last quarter.
Aarti Drugs share price range
|
| ||||
|
| ||||
Aarti Drugs share Key Metrics
| Market Cap ( ₹ Cr.) | 4,100.31 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Aarti Drugs Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 24-Oct-24 | Quarterly Results |
| 26-Aug-24 | Buy Back of Shares |
| 26-Jul-24 | Quarterly Results |
| 03-May-24 | Audited Results |
| 24-Jan-24 | Quarterly Results & Interim Dividend |
| 19-Oct-23 | Quarterly Results |
| 21-Jul-23 | Quarterly Results & Buy Back |
| 29-Apr-23 | Audited Results |
| 27-Jan-23 | Quarterly Results & Interim Dividend |
| 20-Oct-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 26-Sep-23 | 29-Apr-23 | AGM |
| 04-Aug-22 | 11-Jul-22 | AGM |
| 04-Sep-21 | 11-Aug-21 | AGM |
| - | 26-Aug-24 | Others |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 24-Jan-24 | 06-Feb-24 | 06-Feb-24 | 1 |
| 27-Jan-23 | 08-Feb-23 | 08-Feb-23 | 1 |
| 31-Jan-22 | 10-Feb-22 | 09-Feb-22 | 1 |
FAQs about Aarti Drugs share price
Aarti Drugs is trading at 453.70 as on Mon Nov 25 2024 10:22:55. This is 1.05% upper as compared to its previous closing price of 449.00.
The market capitalization of Aarti Drugs is 4100.31 Cr as on Mon Nov 25 2024 10:22:55.
The 52 wk high for Aarti Drugs is 634.90 whereas the 52 wk low is 430.00
Aarti Drugs can be analyzed on the following key metrics -
- TTM P/E: 30.88
- Sector P/E: 33.29
- Dividend Yield: 0.00%
- D/E ratio: 0.46
Aarti Drugs reported a net profit of 171.43 Cr in 2024.
Aarti Drugs Quick Links
Aarti Drugs Dividend Aarti Drugs Bonus Aarti Drugs News Aarti Drugs AGM Aarti Drugs Rights Aarti Drugs Splits Aarti Drugs Board Meetings Aarti Drugs Key Metrics Aarti Drugs Shareholdings Aarti Drugs Profit Loss Aarti Drugs Balance Sheet Aarti Drugs Cashflow Aarti Drugs Q1 Results Aarti Drugs Q2 Results Aarti Drugs Q3 Results Aarti Drugs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks